ADC Asia Congress 2027 (#ADCAsia) | Solution Provider (SG)

Venue & ticket info

Asia’s Leading ADC R&D & Manufacturing Conference – Uniting Asia Leaders in Antibody- Drug Conjugates market. ADC Asia Congress 2027 is the region’s premier gathering dedicated to advancing Antibody-Drug Conjugates (ADCs), bringing together global innovators, biopharma leaders, researchers, manufacturers, investors, and solution providers from across the Asia-Pacific ecosystem. As ADCs continue to reshape the future of targeted cancer therapies, the congress serves as a strategic platform to explore the latest breakthroughs in discovery, conjugation technologies, payload development, manufacturing, clinical development, regulatory strategies, and commercialisation. Designed to foster collaboration and accelerate innovation, the conference features high-level keynote presentations, technical case studies, panel discussions, and networking opportunities with leading pharmaceutical and biotechnology companies from across Asia and beyond. ADC Asia Congress 2027 offers attendees unparalleled access to industry insights, emerging trends, strategic partnerships, and business opportunities driving the next generation of precision medicine and oncology therapeutics.